Clinical Study
Stem Cell Transplants and Disease Prevention for Children with ALL, AML, or MDS
Acute lymphocytic leukemia (ALL) is a type of blood and bone marrow cancer. Acute myeloid leukemia (AML) is a type of blood cell and bone marrow cancer caused by too many undeveloped white blood cells. Myelodysplastic Syndromes (MDS) are a rare group of bone marrow disorders, known as blood cancer. We want to learn if patients receiving stem cell transplants from donors of any type (related, unrelated, cord, or haploidentical) with specific characteristics (different genetic make-up known as polymorphisms) will have better results than those with different transplants. We want to see if fewer diseases such as Graft v Host Disease (GvHD) and other disorders occur. The information we gain may aid future patients.
For more information contact:
Karely Mann
karely.mann@hci.utah.edu
801-587-4019
IRB#: IRB_00153852
| PI: Michael Pulsipher
| Department: PEDIATRIC HEMATOLOGY/ONCOLOGY
| Approval Date: 2023-04-05 06:00:00
Specialties: Pediatric Hematology & Oncology
Who can participate?
Gender: All
Age: All Ages
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria:
- < 25 years for receiving transplants
- 4 months and older for donors
- Diagnosis of ALL, AML, MDS
- High risk with first or second remission of ALL, AML, MDA
- In-person at the University of Utah
Exclusion Criteria:
- Pregnant
- Diagnosis of HIV
- Active CNS (central nervous system) ALL
- Diagnosed genetic disorder(s)
Will I be paid for my time?
No